Agency Resources and Planned Performance - Health
Transcript of Agency Resources and Planned Performance - Health
503
NH
MR
C
National Health and Medical Research Council
Health and Ageing Portfolio Agency
Section 1: Agency Overview and Resources
1.1: Strategic Direction Statement ................................................................ 504
1.2: Agency Resource Statement ................................................................. 505
1.3: Budget Measures .................................................................................. 506
Section 2: Outcomes and Planned Performance
2.1: Outcomes and Performance Information ............................................... 507
Section 3: Explanatory Tables and Budgeted Financial Statements
3.1: Explanatory Tables ............................................................................... 512
3.2: Budgeted Financial Statements ............................................................. 513
NHMRC - Agency Budget Statements – Budgeted Financial Statements
504
Section 1: Agency Overview and Resources
1.1 Strategic Direction Statement
The National Health and Medical Research Council (NHMRC) is the Australian Government’s key agency for managing investment in health and medical research. NHMRC is also responsible for developing evidence-based health advice for the Australian community, health professionals and governments, and for providing advice on ethical practice in health care and in the conduct of health and medical research.
The role and functions of NHMRC are set out in the National Health and Medical Research Council Act (1992). NHMRC also has statutory obligations under the Prohibition of Human Cloning for Reproduction Act (2002) and the Research Involving Human Embryos Act (2002). NHMRC is prescribed as an agency under the Financial Management and Accountability Act (1997).
NHMRC - Agency Budget Statements – Agency Overview and Resources
505
NH
MR
C
1.2 Agency Resources
Table 1.2.1 shows the total resources from all origins. The table summarises how resources will be applied by outcome and by Departmental classifications.
Table 1.2.1 NHMRC Resource Statement – Budget Estimates for 2013-14 as at Budget May 2013
Estimate of prior year
amounts available in
2013-14 $'000
Proposed at Budget
2013-14 $'000
Total estimate
2013-14 $'000
Estimated available
appropriation
2012-13 $'000
Ordinary annual services1
Departmental appropriation
Prior year departmental appropriation2 13,005 - 13,005 16,369
Departmental appropriation3 - 40,273 40,273 39,944
s31 Relevant agency receipts - 3,150 3,150 3,150
Total 13,005 43,423 56,428 59,463
Administered resources1
Outcome 1 - 783,640 783,640 697,165
Total - 783,640 783,640 697,165
Total ordinary annual services 13,005 827,063 840,068 756,628
Other services - Bill 24
Departmental non-operating
Equity injections - - - -
Total - - - -
Total other services - - - -
Total available annual appropriations 13,005 827,063 840,068 756,628
Total appropriations excluding Special Accounts 13,005 827,063 840,068 756,628
Special Accounts
Opening balance5 206,764 - 206,764 267,396
Appropriation receipts6 - 771,187 771,187 689,326
Non-appropriation receipts to Special Accounts - 11,050 11,050 11,050
Total Special Accounts 206,764 782,237 989,001 967,772
Total resourcing 219,769 1,609,300 1,829,069 1,724,400
Less appropriations drawn from annual or special appropriations above and credited to Special Accounts and/or CAC Act bodies through annual appropriations - (771,187) (771,187) (689,326)
Total net resourcing for NHMRC 219,769 838,113 1,057,882 1,035,074
Notes:
All figures are GST exclusive. 1 Appropriation Bill (No.1) 2013-14. 2 Estimated adjusted balance carried from previous year for annual appropriations. 3 Includes an amount of $.082m in 2013-14 for the Departmental Capital Budget (refer to Table 3.2.5 for further
details). For accounting purposes this amount has been designated as 'contributions by owners'. 4 Appropriation Bill (No.2) 2013-14. 5 Estimated opening balance for special accounts. For further information on special accounts see Table 3.1.2. 6 Appropriation receipts from NHMRC annual and special appropriations for 2013-14 included above.
NHMRC - Agency Budget Statements – Budgeted Financial Statements
506
1.3 Budget Measures
Budget measures relating to NHMRC are detailed in Budget Paper No. 2 and are summarised below.
Table 1.3.1: NHMRC Budget Measures
Part 1: Measures announced since the 2012-13 MYEFO
Program 2012-13 2013-14 2014-15 2015-16 2016-17
$'000 $'000 $'000 $'000 $'000
Acute rheumatic fever vaccine - research
National Health and Medical Research Council
Administered expenses 1.1 - 600 730 - -
Departmental expenses - 33 60 - -
Total - 633 790 - -
Other Portfolio Measures
A Plan for Australian Jobs - Clinical Trials Reform in Australia
National Health and Medical Research Council
Administered expenses 1.1 - 680 306 281 284
Departmental expenses - 442 759 768 774
Total - 1,122 1,065 1,049 1,058
Part 2: MYEFO measures not previously reported in a portfolio statement
Whole of Government Measures
Targeted savings - public service efficiencies1
National Health and Medical Research Council
Departmental expenses 1.1 (533) (698) (699) (703) (688)
Total (533) (698) (699) (703) (688)
1 Measure reported incudes amounts previously reported in the Health and Ageing 2012-13 Portfolio Additional Estimate Statements (page 25).
NHMRC - Agency Budget Statements – Agency Overview and Resources
507
NH
MR
C
Section 2: Outcomes and Planned Performance
2.1 Outcomes and Performance Information
Outcome 1 – Improved health and medical knowledge, including through funding research, translating research findings into evidence-based clinical practice, administering legislation governing research, issuing guidelines and advice
for ethics in health and the promotion of public health
Outcome Strategy
The Australian Government, through NHMRC, invests in health and medical research that is undertaken within a well-established ethical framework, to address national health priorities and improve the health status of all Australians.
Health and medical research is vital in driving improvements throughout the health system. It also supports the development of rigorous, evidence-based advice for both health practitioners and the Australian community.
The Australian Government, through NHMRC, will build Australia’s research capacity and international standing by investing in innovative research, and the individuals and facilities needed to support such research. NHMRC’s work will also facilitate the translation of evidence derived from health and medical research into practices and systems designed to prevent illness and improve public health.
It can take more than 20 years for knowledge, created through research, to be translated into health interventions and applied in clinical settings. 1 This means that the Government’s investment in health and medical research produces benefits for the Australian community well into the future.
NHMRC will maximise this investment through collaboration with regional neighbours to address common health challenges and, more widely, to facilitate access by Australian researchers and health professionals to sources of international funding and the best collaborative networks and research facilities. Engaging with international research partners provides opportunities for Australia to be involved in developing international policies and initiatives in research governance, and explore emerging fields of health and medical research for the benefit of all Australians. The NHMRC Strategic Plan 2013-20152 identifies the priorities for NHMRC to achieve these outcomes.
1 Trochim W, Kane C, Graham M, Pincus H. - Evaluating Translational Research: A Process Marker Model. In: Clinical
and Translation Science, 2011,Volume 4 – Issue 3, pp. 153-162.
2 Available at: www.nhmrc.gov.au
NHMRC - Agency Budget Statements – Budgeted Financial Statements
508
NHMRC Budgeted Expenses and Resources
Table 2.1.1 provides an overview of the total expenses for NHMRC by Program.
Table 2.1.1: Budgeted Expenses and Resources for NHMRC
2012-13 Estimated
actual $'000
2013-14 Budget
$'000
2014-15 Forward
year 1 $'000
2015-16 Forward
year 2 $'000
2016-17 Forward
year 3 $'000
Program 1.1: Health and medical research
Administered expenses
Ordinary annual services 697,165 783,640 872,259 811,845 826,458 to the Medical Research
Endowment Account (689,326) (771,187) (859,870) (800,222) (814,627)
Special accounts Medical Research Endowment
Account 761,008 858,576 930,902 859,737 839,792
Departmental expenses
Departmental appropriation1 43,013 43,341 43,939 44,228 44,653
Expenses not requiring appropriation in the budget year
2 1,901 1,901 1,901 1,901 1,901
Operating deficit (surplus) 1,400 1,400 1,400 - -
Total for Program 1.1 815,161 917,671 990,531 917,489 898,177
Total expenses for Outcome 1 815,161 917,671 990,531 917,489 898,177
2012-13 2013-14 Average staffing level (number) 215 217
1 Departmental appropriation combines "Ordinary annual services (Appropriation Bill No 1)" and "Revenue from independent sources (s31)".
2 Expenses not requiring appropriation in the Budget year is made up of depreciation expense, amortisation
expense, makegood expense and audit fees.
NHMRC - Agency Budget Statements – Agency Overview and Resources
509
NH
MR
C
Program 1.1: Health and medical research
Program Objectives
Support high quality health and medical research
In 2013-14, NHMRC will implement two new measures to support essential research in Australia.
Over 4 years, NHMRC will, in conjunction with the Department of Innovation, Industry, Climate Change, Science, Research and Tertiary Education (DIICCSRTE) and agencies within the Health Portfolio, conduct work to better support the clinical trials sector in Australia. This work will build on that previously completed in response to the recommendations of the Clinical Trials Action Group Report. It will enable NHMRC to work with the states and territories and other stakeholders on the continued implementation of a nationally consistent approach to streamlining research governance and ethics review arrangements for clinical trials in the public and private sectors.
In addition, NHMRC will develop education, guidance and support for clinical trials proponents for the preparation and submission of applications for ethics and governance approval. Finally, the initiative will allow NHMRC in conjunction with DIICCSRTE to work on the development of a national interactive portal to enable greater participation and engagement in clinical trials.
In recognition that Australia has the highest documented rate of Group A Streptococcus (GAS disease) internationally,3 NHMRC will also implement a new initiative conjointly with its counterpart, the Health Research Council (HRC) of New Zealand to develop a vaccine. One of the critical impacts of GAS disease for affected Indigenous peoples is its contribution to their burden of shorter lifespan. An effective vaccine would contribute to the overall efforts in the Australian health sector to Close the Gap.
The Australian Government, through NHMRC, will build Australia’s research capacity and international standing by supporting both people and facilities undertaking innovative research. Through the Medical Research Endowment Account,4 NHMRC will award grants through a number of funding schemes to support research in all areas of health, targeting special areas of need such as Aboriginal and Torres Strait Islander health.
Support the translation of health and medical research
The Australian Government recognises the importance of translating research to drive improvements throughout the health system. In 2013-14, NHMRC will commence work with its new Research Translation Faculty to identify the most important evidence gaps in major health issues and develop evidence-based actions to address them. NHMRC will also develop evidence-based health advice
3 Source: Carapetis, J.R., A.C. Steer et al. (2005) ‘The global burden of group A streptococcal diseases’. Lancet Infect
Dis 5(11):685-694. 4 The Medical Research Endowment Account is a special account established under the National Health and Medical
Research Council Act (1992). Payments are made from the account to government departments, universities, institutions or people engaged in medical research and for assistance in training people in medical research.
NHMRC - Agency Budget Statements – Budgeted Financial Statements
510
and guidelines in areas such as lead (safe blood levels), alternative therapies, windfarms and health, and genomics.
Promote the highest ethical standards in health and medical research
The Australian Government is committed to ensuring that the health and medical research undertaken in Australia is of the highest ethical standard. In 2013-14, NHMRC will monitor funding recipients to ensure they comply with the Australian Code for the Responsible Conduct of Research (2007). NHMRC will advise human
research ethics committees that undertake the ethical review of research involving humans and monitor the conduct of research, as well as provide advice to institutions and researchers. NHMRC will also encourage the continued uptake of the National Approach to Single Ethical Review initiative (formerly known as the Harmonisation of Multi-centre Ethical Review (HoMER)) within public and private hospitals and in universities. NHMRC will revise sections of the National Statement on Ethical Conduct in Human Research 2007, Part B of the Ethical Guidelines on the use of Assisted Reproductive Technology in Clinical Practice and Research, June 2007 and finalise the revision of the Australian Code of Practice for the Care and Use of Animals for Scientific Purposes, 2004.
NHMRC will continue to administer the Research Involving Human Embryos Act (2002) and the Prohibition of Human Cloning for Reproduction Act (2002). These Acts prohibit certain practices, including human cloning for reproduction and restrict other practices relating to reproductive technology and research.
Program 1.1: Deliverables
Qualitative Deliverable for Program 1.1
Support high quality health and medical research
Qualitative Deliverable 2013-14 Reference Point or Target
Funding provided for high quality research into Australian health problems
Use of targeted and urgent calls to support research into specific health problems
Quantitative Deliverables for Program 1.1
Support high quality health and medical research
Quantitative Deliverables 2012-13 Revised Budget
2013-14 Budget Target
2014-15 Forward Year 1
2015-16 Forward Year 2
2016-17 Forward Year 3
Percentage of total Medical Research Endowment Account funding to the NHMRC Project Grant scheme
50% 50% 50% 50% 50%
Percentage of annual research budget awarded to Indigenous health research
>5% >5% >5% >5% >5%
NHMRC - Agency Budget Statements – Agency Overview and Resources
511
NH
MR
C
Program 1.1: Key Performance Indicators
Qualitative Key Performance Indicators for Program 1.1
Support high quality health and medical research
Qualitative Indicator 2013-14 Reference Point or Target
Periodic review of established funding schemes to determine strengths and identify where improvements can be made
Completed reviews are presented to Research Committee for consideration, and implemented according to established timelines
Promote the highest ethical standards in health and medical research
Qualitative Indicator 2013-14 Reference Point or Target
National adoption of the National Approach to Single Ethical Review initiative (formerly
known as HoMER)
Increased uptake of the National Approach to Single Ethical Review certification by Human Research Ethics Committees.
Quantitative Key Performance Indicators for Program 1.1
Support the translation of health and medical research
Quantitative Indicator
2012-13 Revised Budget
2013-14 Budget Target
2014-15 Forward Year 1
2015-16 Forward Year 2
2016-17 Forward Year 3
Citation rate (number of citations divided by the number of scientific publications in a given time period) of journal articles resulting from NHMRC funded research5
>50% >50% >50% >50% >50%
Promote the highest ethical standards in health and medical research
Quantitative Indicator
2012-13 Revised Budget
2013-14 Budget Target
2014-15 Forward Year 1
2015-16 Forward Year 2
2016-17 Forward Year 3
Percentage of researcher and institutional compliance with ethics codes and human embryo licensing conditions
100% 100% 100% 100% 100%
5 Bibliographic citations are where a journal article is referenced in a subsequent journal article, indicating some
scientific impact of the original work. The citation rate of journal articles resulting from NHMRC funded research (above) is compared to the world citation average, which is determined by dividing the total number of citations,
by the total number of journal articles published in the world in the same time period.
NHMRC - Agency Budget Statements – Budgeted Financial Statements
512
Section 3: Explanatory Tables and Budgeted Financial Statements
Section 3 presents explanatory tables and budgeted financial statements which provide a comprehensive snapshot of agency finances for the 2013-14 Budget year. It explains how budget plans are incorporated into the financial statements and provides further details of the reconciliation between appropriations and program expenses, movements in administered funds, special accounts and government Indigenous expenditure.
3.1 Explanatory Tables
3.1.1 Movement of administered funds between years
Table 3.1.1: Movement of Administered Funds between Years1
2012-13 2013-14 2014-15 2015-16 2016-17
$'000 $'000 $'000 $'000 $'000
Outcome 1
1.1 Health and medical research2 (74,300) - 74,300 - -
Total movement of administered funds
(74,300) - 74,300 - -
1 Figures displayed as a negative (-) represent a decrease in funds and a positive reflect an increase in funds. 2 The movement of funds for NHMRC reflects an administrative change to payment arrangements. The change to
the timing of grant payments has no impact on the current level of grant funding or existing funding
commitments, nor does it impact upon individual research projects or researchers.
3.1.2 Special Accounts
Table 3.1.2: Estimates of Special Account Flows and Balances - NHMRC
Outcome
Opening balance 2013-14 2012-13
$'000
Appropriation receipts 2013-14 2012-13
$'000
Other receipts 2013-14 2012-13
$'000
Payments
2013-14 2012-13
$'000
Closing balance 2013-14 2012-13
$'000
Medical Research 1 206,764 771,187 51,050 898,576 130,425
Endowment Account1 (A)
267,396 689,326 51,050 801,008 206,764
Total Special Accounts
2013-14 Estimate 206,764 771,187 51,050 898,576 130,425
Total Special Accounts
2012-13 estimate actual 267,396 689,326 51,050 801,008 206,764 Notes: D = Departmental; A = Administered. 1 National Health and Medical Research Council Act 1992 - s21 FMA Act.
NHMRC - Agency Budget Statements – Agency Overview and Resources
513
NH
MR
C
3.1.3 Australian Government Indigenous Expenditure (AGIE)
Outcome Appropriations Other Total
Bill No. 1 $'000
Bill No. 2 $'000
Special appropriations
$'000
Total appropriations
$'000
$'000
$'000
National Health and Medical Research Council
Administered 2013-14 47,093 - - 47,093 - 47,093 Administered 2012-13 41,741 - - 41,741 - 41,741
Departmental 2013-14 308 - - 308 - 308
Departmental 2012-13 294 - - 294 - 294
Total outcome 2013-14 47,401 - - 47,401 - 47,401
Total outcome 2012-13 42,035 - - 42,035 - 42,035
Total AGIE 2013-14 47,401 - - 47,401 - 47,401
Total AGIE 2012-13 42,035 - - 42.035 - 42.035
3.2 Budgeted Financial Statements
3.2.1 Differences in agency resourcing and financial statements
Section 3.2.1 is not applicable to NHMRC.
3.2.2 Analysis of budgeted financial statements
An analysis of NHMRC’s budgeted financial statements for 2013-14 is set out below.
Departmental Resources
Comprehensive Income Statement (Showing Net Cost of Services)
Revenue and expenditure for 2013-14 is expected to be in line with Government forecasts, with Employee expenses to be approximately 54% of total expenditure.
Balance Sheet
The Receivables include funding for the Australia Research Fellowship scheme appropriated in 2006-07 which will be drawn down annually to facilitate the approved $1.400 million loss per annum until 30 June 2015.
Administered Resources
The Administered accounts are used as a mechanism to transfer most of the funds to NHMRC’s Special Account (Medical Research Endowment Account). In 2013-14 the transfer to the Special Account is expected to be $771.187 million. The balance of the Administered Appropriation in 2013-14 will be used to fund new measures ($1.280 million) and programs transferred from Department of Health and Ageing ($11.173 million) in the 2011-12 Budget.
In 2012-13 an initiative to change grant funding payments from quarterly in advance to monthly in arrears resulted in a re-profiling of $74.3 million from 2012-13 to 2014-15.
Expenditure in 2013-14 and forward estimates is expected to be greater than the Administered Appropriations and funds will be drawn down from the Medical Research Endowment Account.
NHMRC - Agency Budget Statements – Budgeted Financial Statements
514
3.2.3 Budgeted financial statements tables
Table 3.2.1: Comprehensive income statement (showing net cost of services) (for the period ended 30 June)
Estimated actual
2012-13 $'000
Budget estimate 2013-14
$'000
Forward estimate 2014-15
$'000
Forward estimate 2015-16
$'000
Forward estimate 2016-17
$'000
EXPENSES
Employee benefits 24,933 25,099 25,320 25,564 25,764
Supplier expenses 19,580 19,742 20,119 18,764 18,989
Depreciation and amortisation 1,801 1,801 1,801 1,801 1,801
Total expenses 46,314 46,642 47,240 46,129 46,554
LESS:
OWN-SOURCE INCOME
Revenue Sale of goods and rendering of
services 3,150 3,150 3,150 3,150 3,150
Total revenue 3,150 3,150 3,150 3,150 3,150
Gains
Other 100 100 100 100 100
Total gains 100 100 100 100 100
Total own-source income 3,250 3,250 3,250 3,250 3,250
Net cost of (contribution by) services 43,064 43,392 43,990 42,879 43,304
Revenue from Government 39,863 40,191 40,789 41,078 41,503
Surplus (Deficit) (3,201) (3,201) (3,201) (1,801) (1,801)
Surplus (Deficit) attributable to the Australian Government (3,201) (3,201) (3,201) (1,801) (1,801)
OTHER COMPREHENSIVE INCOME
Changes in asset revaluation reserves - - - - -
Total other comprehensive income - - - - -
Total comprehensive income attributable to the Australian Government (3,201) (3,201) (3,201) (1,801) (1,801)
Note: Reconciliation of comprehensive income attributable to the agency
2012-13 2013-14 2014-15 2015-16 2016-17
$'000 $'000 $'000 $'000 $'000
Total comprehensive income (loss) attributable to the Australian Government (3,201) (3,201) (3,201) (1,801) (1,801)
plus non-appropriated expenses depreciation and amortisation expenses 1,801 1,801 1,801 1,801 1,801
Total comprehensive income (loss) attributable to the agency (1,400) (1,400) (1,400) - -
NHMRC - Agency Budget Statements – Agency Overview and Resources
515
NH
MR
C
Table 3.2.2: Budgeted Departmental balance sheet (as at 30 June)
Estimated actual
2012-13 $'000
Budget estimate 2013-14
$'000
Forward estimate 2014-15
$'000
Forward estimate 2015-16
$'000
Forward estimate 2016-17
$'000
ASSETS
Financial assets
Cash and cash equivalents 343 343 343 343 343
Receivables 13,745 12,426 12,714 13,143 13,686
Total financial assets 14,088 12,769 13,057 13,486 14,029
Non-financial assets
Property, plant and equipment 6,166 5,062 3,958 2,854 1,750
Inventories 245 245 245 245 245
Intangibles 5,016 4,501 3,990 3,478 2,969
Other 94 94 94 94 94
Total non-financial assets 11,521 9,902 8,287 6,671 5,058
Total assets 25,609 22,671 21,344 20,157 19,087
LIABILITIES
Payables
Suppliers 3,461 3,461 3,461 3,461 3,461
Other payables 2,669 2,291 1,989 1,747 1,554
Total payables 6,130 5,752 5,450 5,208 5,015
Provisions
Employees 5,913 6,448 7,013 7,658 8,367
Other provisions 600 624 649 675 702
Total provisions 6,513 7,072 7,662 8,333 9,069
Total liabilities 12,643 12,824 13,112 13,541 14,084
Net Assets 12,966 9,847 8,232 6,616 5,003
EQUITY
Contributed equity 5,275 5,357 5,543 5,728 4,801
Retained surpluses or accumulated deficits 7,691 4,490 2,689 888 202
Total equity 12,966 9,847 8,232 6,616 5,003
NHMRC - Agency Budget Statements – Budgeted Financial Statements
516
Table 3.2.3: Departmental statement of changes in equity — summary of movement (Budget year 2013-14)
Retained earnings
$'000
Asset revaluation
reserve $'000
Other reserves
$'000
Contributed equity/ capital
$'000
Total equity
$'000
Opening balance as at 1 July 2013 Balance carried forward from
previous period 7,691 - - 5,275 12,966
Surplus (deficit) for the period (3,201) - - - (3,201)
Appropriation (equity injection) - - - - -
Capital budget - Bill 1 (DCB) - - - 82 82
Other movements - - - -
Estimated closing balance as at 30 June 2014 4,490 - - 5,357 9,847
DCB = Departmental Capital Budget.
NHMRC - Agency Budget Statements – Agency Overview and Resources
517
NH
MR
C
Table 3.2.4: Budgeted Departmental statement of cash flows (for the period ended 30 June)
Estimated actual
2012-13 $'000
Budget estimate 2013-14
$'000
Forward estimate 2014-15
$'000
Forward estimate 2015-16
$'000
Forward estimate 2016-17
$'000
OPERATING ACTIVITIES
Cash received
Goods and services 3,150 3,150 3,150 3,150 3,150
Appropriations 43,755 41,232 40,479 40,690 40,643
Net GST received 1,500 1,500 1,500 1,500 1,500
Total cash received 48,405 45,882 45,129 45,340 45,293
Cash used
Employees 26,574 24,564 24,755 23,963 25,055
Suppliers 19,934 21,218 20,374 21,377 20,238
Total cash used 46,508 45,782 45,129 45,340 45,293 Net cash from (or used by)
operating activities 1,897 100 - - -
INVESTING ACTIVITIES
Cash used Purchase of property, plant and
equipment 1,978
182 186 185 188
Total cash used 1,978 182 186 185 188 Net cash from (or used by)
investing activities (1,978) (182) (186) (185) (188)
FINANCING ACTIVITIES
Cash received Appropriations - contributed
equity 81
82 186 185 188
Total cash received 81 82 186 185 188 Net cash from (or used by)
financing activities 81 82 186 185 188
Net increase (or decrease) in cash held - - - - - Cash and cash equivalents at the
beginning of the reporting period 343 343 343 343 343 Cash and cash equivalents at the
end of the reporting period 343 343 343 343 343
NHMRC - Agency Budget Statements – Budgeted Financial Statements
518
Table 3.2.5: Capital budget statement
Estimated actual
2012-13 $'000
Budget estimate 2013-14
$'000
Forward estimate 2014-15
$'000
Forward estimate 2015-16
$'000
Forward estimate 2016-17
$'000
CAPITAL APPROPRIATIONS
Capital budget - Bill 1 (DCB) 81 82 186 185 188
Equity injections - Bill 2 - - - - -
Total capital appropriations 81 82 186 185 188
Total new capital appropriations represented by:
Purchase of non-financial assets 81 82 186 185 188
Total items 81 82 186 185 188
PURCHASE OF NON-FINANCIAL ASSETS
Funded by capital appropriations - - - - - Funded by capital appropriation -
DCB1 81 82 186 185 188
Funded internally from departmental resources 1,897 100 - - -
Total acquisitions of non-financial assets 1,978 182 186 185 188
RECONCILIATION OF CASH USED TO ACQUIRE ASSETS TO ASSET MOVEMENT TABLE
Total purchases 1,978 182 186 185 188 Total cash used to acquire
assets 1,978 182 186 185 188
1 Does not include annual finance lease costs. Includes purchases from current and previous years' appropriation (Departmental Capital Budget).
NHMRC - Agency Budget Statements – Agency Overview and Resources
519
NH
MR
C
Table 3.2.6: Statement of asset movements (2013-14)
Buildings
$'000
Other property, plant and
equipment $'000
Intangibles
$'000
Total
$'000
As at 1 July 2013
Gross book value - 10,505 8,272 18,777 Accumulated depreciation/amortisation
and impairment - 4,339 3,256 7,595
Opening net book balance - 6,166 5,016 11,182
CAPITAL ASSET ADDITIONS Estimated expenditure on new or
replacement assets
By purchase - appropriation equity - - - -
By purchase - appropriation
ordinary annual services - - 82 82
By purchase - other - - 100 100
Sub-total - - 182 182
Other movements
Depreciation/amortisation expense - 1,104 697 1,801
Disposals1 - - - -
Other - - - -
As at 30 June 2014
Gross book value - 10,505 8,454 18,959 Accumulated depreciation/amortisation and
impairment - 5,443 3,953 9,396
Closing net book balance - 5,062 4,501 9,563
1 Proceeds may be returned to the Official Public Account.
NHMRC - Agency Budget Statements – Budgeted Financial Statements
520
Table 3.2.7: Schedule of Budgeted Income and Expenses Administered on Behalf of Government (for the period ended 30 June)
Estimated actual
2012-13 $'000
Budget estimate 2013-14
$'000
Forward estimate 2014-15
$'000
Forward estimate 2015-16
$'000
Forward estimate 2016-17
$'000 INCOME ADMINISTERED ON
BEHALF OF GOVERNMENT
Recoveries 7,000 7,000 7,000 5,000 5,000
Other non-tax revenue 4,050 4,050 3,600 3,000 3,000 Total income administered on
behalf of Government 11,050 11,050 10,600 8,000 8,000
EXPENSES ADMINISTERED ON BEHALF OF GOVERNMENT
Grants - MREA 761,008 858,576 930,902 859,737 839,792
Grants - other 7,839 12,453 12,389 11,623 11,831 Total expenses administered on
behalf of Government 768,847 871,029 943,291 871,360 851,623
Table 3.2.8: Schedule of Budgeted Assets and Liabilities Administered on Behalf of Government (as at 30 June)
Estimated actual
2012-13 $'000
Budget estimate 2013-14
$'000
Forward estimate 2014-15
$'000
Forward estimate 2015-16
$'000
Forward estimate 2016-17
$'000
ASSETS ADMINISTERED ON BEHALF OF GOVERNMENT
Financial assets
Cash and cash equivalents - - - - -
Receivables 3,964 3,964 3,964 3,964 3,964
Total financial assets 3,964 3,964 3,964 3,964 3,964
Total assets administered on behalf of Government 3,964 3,964 3,964 3,964 3,964
LIABILITIES ADMINISTERED ON BEHALF OF GOVERNMENT
Payables
Grants 12,408 10,408 6,408 4,408 4,408
Total payables 12,408 10,408 6,408 4,408 4,408
Total liabilities administered on behalf of Government 12,408 10,408 6,408 4,408 4,408
NHMRC - Agency Budget Statements – Agency Overview and Resources
521
NH
MR
C
Table 3.2.9: Schedule of Budgeted Administered Cash Flows (for the period ended 30 June)
Estimated actual
2012-13 $'000
Budget estimate 2013-14
$'000
Forward estimate 2014-15
$'000
Forward estimate 2015-16
$'000
Forward estimate 2016-17
$'000
OPERATING ACTIVITIES
Cash received
Cash Received - Other 11,050 11,050 10,600 8,000 8,000
Net GST received 40,000 40,000 40,000 40,000 40,000
Total cash received 51,050 51,050 50,600 48,000 48,000
Cash used
Grant payments - MREA 761,008 858,576 930,902 859,737 839,792
Grant payments - other 7,839 12,453 12,389 11,623 11,853
Net GST paid 40,000 40,000 40,000 40,000 40,000
Total cash used 808,847 911,029 983,291 911,360 891,645
Net cash from (or used by)
operating activities (757,797) (859,979) (932,691) (863,360) (843,645) Net increase (or decrease) in
cash held (757,797) (859,979) (932,691) (863,360) (843,645)
Cash at beginning of reporting period - - - - -
Cash from Official Public Account for:
- appropriations 757,797 859,979 932,691 863,360 843,645
Cash at end of reporting period - - - - -